Espinoza Octavio
Insider CIK 1905248 · LGND Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,171 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 3,348 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 16,179 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 2,869 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 2,074 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 2,869 | $55.75 | $159.9K | 48,818 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 2,074 | $70.04 | $145.3K | 45,949 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-12 | 2026-08-14 | 31,641 | $292.07 | $9.24M | 27,696 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 7,171 | $57.22 | $410.3K | 55,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 3,348 | $68.74 | $230.1K | 59,337 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 16,179 | $52.84 | $854.9K | 43,875 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 2,074 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 3,348 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 16,179 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,171 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-12 | 2026-08-14 | 2,869 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-12 | 2026-08-14 | 31,641 | $292.06 | $9.24M | 27,696 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 3,348 | $68.74 | $230.1K | 59,337 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 7,171 | $57.22 | $410.3K | 55,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 2,869 | $55.75 | $159.9K | 48,818 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 2,074 | $70.04 | $145.3K | 45,949 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-12 | 2026-08-14 | 16,179 | $52.84 | $854.9K | 43,875 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2026-06-30 | 2026-07-06 | 17 | $160.71 | $2.7K | 27,696 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-05-27 | 2026-05-28 | 972 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-05-27 | 2026-05-28 | 764 | — | $0 | 17,407 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-05-27 | 2026-05-28 | 764 | $63.62 | $48.6K | 26,707 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-05-27 | 2026-05-28 | 972 | $52.84 | $51.4K | 27,679 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-03-11 | 2026-03-13 | 2,405 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-11 | 2026-03-13 | 3,057 | $225.00 | $687.8K | 21,010 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-03-11 | 2026-03-13 | 2,405 | $92.65 | $222.8K | 24,067 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-03-04 | 2026-03-06 | 466 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-03-04 | 2026-03-06 | 1,607 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 1,588 | $206.89 | $328.5K | 27,532 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 1,457 | $205.79 | $299.8K | 29,120 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 743 | $204.74 | $152.1K | 30,577 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 668 | $203.63 | $136.0K | 31,320 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 697 | $202.79 | $141.3K | 31,988 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 698 | $201.09 | $140.4K | 33,635 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 53 | $200.08 | $10.6K | 34,333 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 699 | $198.71 | $138.9K | 34,386 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-03-04 | 2026-03-06 | 466 | $80.72 | $37.6K | 35,085 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-03-04 | 2026-03-06 | 1,607 | $58.49 | $94.0K | 34,619 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 2,457 | $207.91 | $510.8K | 25,075 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 3,413 | $208.80 | $712.6K | 21,662 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 950 | $201.73 | $191.6K | 32,685 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-03-02 | 2026-03-27 | 23,527 | — | $0 | 23,527 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-03-02 | 2026-03-27 | 4,933 | — | $0 | 37,945 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 1,223 | $183.83 | $224.8K | 34,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 1,270 | $183.83 | $233.5K | 33,012 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 1,026 | $183.83 | $188.6K | 35,505 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-02-14 | 2026-02-18 | 7,390 | — | $0 | 35,965 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-14 | 2026-02-18 | 3,761 | $183.83 | $691.4K | 32,204 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-02-14 | 2026-02-18 | 8,810 | — | $0 | 41,014 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-14 | 2026-02-18 | 4,483 | $183.83 | $824.1K | 36,531 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2025-12-31 | 2026-01-06 | 8 | $95.68 | $765 | 28,575 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-12-16 | 2025-12-18 | 1,194 | — | $0 | 972 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-12-16 | 2025-12-18 | 69 | — | $0 | 7,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-12-16 | 2025-12-18 | 652 | — | $0 | 2,405 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-12-16 | 2025-12-18 | 181 | — | $0 | 4,186 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-12-16 | 2025-12-18 | 285 | — | $0 | 18,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-12-16 | 2025-12-18 | 69 | $57.22 | $3.9K | 27,449 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-12-16 | 2025-12-18 | 285 | $63.62 | $18.1K | 27,734 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-12-16 | 2025-12-18 | 652 | $92.65 | $60.4K | 28,386 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-12-16 | 2025-12-18 | 181 | $103.42 | $18.7K | 28,567 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-12-16 | 2025-12-18 | 1,194 | $52.84 | $63.1K | 27,380 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-12-12 | 2025-12-16 | 1,804 | $188.31 | $339.7K | 26,186 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-12-05 | 2025-12-09 | 1,862 | $184.87 | $344.2K | 27,990 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2025-06-30 | 2025-07-02 | 224 | $91.08 | $20.4K | 29,852 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2025-05-09 | 2025-05-13 | 500 | $104.40 | $52.2K | 27,932 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2025-05-09 | 2025-05-13 | 1,000 | $103.89 | $103.9K | 27,432 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-03-04 | 2025-03-06 | 32,717 | — | $0 | 32,717 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-03-04 | 2025-03-06 | 5,000 | $115.03 | $575.1K | 18,879 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-03-04 | 2025-03-06 | 7,484 | — | $0 | 26,363 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 1,221 | $120.00 | $146.5K | 23,879 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 782 | $120.00 | $93.8K | 25,100 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 1,024 | $120.00 | $122.9K | 25,882 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-02-14 | 2025-02-19 | 7,390 | — | $0 | 30,709 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 2,757 | $120.00 | $330.8K | 23,319 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-02-14 | 2025-02-19 | 5,429 | — | $0 | 26,076 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 3,803 | $120.00 | $456.4K | 26,906 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-12-23 | 2024-12-26 | 2,104 | $116.37 | $244.8K | 20,647 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-12-05 | 2024-12-06 | 1,859 | $123.51 | $229.6K | 22,751 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-20 | 2024-09-24 | 275 | $103.86 | $28.6K | 25,410 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-20 | 2024-09-24 | 800 | $103.95 | $83.2K | 24,610 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-20 | 2024-09-24 | 200 | $103.98 | $20.8K | 25,685 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-17 | 2024-09-19 | 1,417 | — | $0 | 466 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-17 | 2024-09-19 | 69 | — | $0 | 7,240 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-17 | 2024-09-19 | 1,417 | $80.72 | $114.4K | 25,816 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-17 | 2024-09-19 | 69 | $57.22 | $3.9K | 25,885 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-08-28 | 2024-08-30 | 207 | — | $0 | 7,309 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-08-28 | 2024-08-30 | 546 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-08-28 | 2024-08-30 | 207 | $57.22 | $11.8K | 23,853 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-08-28 | 2024-08-30 | 546 | $70.04 | $38.2K | 24,399 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2024-06-28 | 2024-07-02 | 267 | $60.71 | $16.2K | 23,646 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-05-17 | 2024-05-17 | 1,544 | — | $0 | 18,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-05-17 | 2024-05-17 | 145 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-05-17 | 2024-05-17 | 5,022 | — | $0 | 16,179 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-05-17 | 2024-05-17 | 206 | — | $0 | 7,516 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-05-17 | 2024-05-17 | 1,544 | $63.62 | $98.2K | 23,368 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-17 | 2024-05-17 | 5,022 | $86.67 | $435.3K | 23,513 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-05-17 | 2024-05-17 | 5,022 | $52.84 | $265.4K | 28,535 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-05-17 | 2024-05-17 | 145 | $68.74 | $10.0K | 23,513 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-17 | 2024-05-17 | 134 | $86.65 | $11.6K | 23,379 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-05-17 | 2024-05-17 | 206 | $57.22 | $11.8K | 21,824 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-16 | 2024-05-17 | 2,264 | $86.00 | $194.7K | 21,618 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-15 | 2024-05-17 | 5,873 | $86.01 | $505.1K | 23,882 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 140 | — | $0 | 7,722 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 325 | — | $0 | 1,607 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 799 | — | $0 | 2,869 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-02-28 | 2024-02-29 | 799 | $55.75 | $44.5K | 29,430 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-02-28 | 2024-02-29 | 325 | $58.49 | $19.0K | 29,895 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-02-28 | 2024-02-29 | 140 | $57.22 | $8.0K | 29,570 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-02-28 | 2024-02-29 | 140 | $88.46 | $12.4K | 29,755 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-02-27 | 2024-02-29 | 29,272 | — | $0 | 29,272 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-02-27 | 2024-02-29 | 7,208 | — | $0 | 28,631 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-02-15 | 2024-02-16 | 1,479 | $74.65 | $110.4K | 21,423 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-12-05 | 2023-12-06 | 1,269 | $59.61 | $75.6K | 22,902 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-10-01 | 2023-10-03 | 346 | $59.92 | $20.7K | 24,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2023-06-30 | 2023-07-10 | 375 | $56.78 | $21.3K | 24,517 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-02-23 | 2023-02-27 | 16,419 | — | $0 | 16,419 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-02-23 | 2023-02-27 | 6,046 | — | $0 | 24,142 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-02-15 | 2023-02-17 | 849 | $72.98 | $62.0K | 18,096 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2022-12-30 | 2023-01-04 | 275 | $56.78 | $15.6K | 18,945 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 6,620 | — | $0 | 6,620 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-13 | 2022-12-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-12-13 | 2022-12-15 | 11,000 | — | $0 | 18,670 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-11-30 | 2022-12-01 | 1,187 | $72.90 | $86.5K | 7,670 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-11-09 | 2022-11-10 | 1,696 | $75.64 | $128.3K | 8,857 | SEC↗ |